Tyra Biosciences (TYRA) Operating Leases (2021 - 2026)
Quarterly Operating Leases fell 8.55% to $5.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.2 million through Mar 2026, down 8.55% year-over-year, with the annual reading at $5.3 million for FY2025, 8.12% down from the prior year.
Tyra Biosciences filings provide 6 years of Operating Leases readings, the most recent being $5.2 million for Q1 2026.
- Operating Leases hit $5.2 million in Q1 2026 for Tyra Biosciences, down from $5.3 million in the prior quarter.
- Across five years, Operating Leases topped out at $6.2 million in Q4 2023 and bottomed at $2.4 million in Q1 2023.
- Average Operating Leases over 5 years is $5.0 million, with a median of $5.6 million recorded in 2025.
- The largest annual shift saw Operating Leases skyrocketed 153.01% in 2022 before it crashed 55.56% in 2023.
- Tyra Biosciences' Operating Leases stood at $2.5 million in 2022, then soared by 150.44% to $6.2 million in 2023, then decreased by 6.53% to $5.8 million in 2024, then dropped by 8.12% to $5.3 million in 2025, then dropped by 2.42% to $5.2 million in 2026.
- Per Business Quant, the three most recent readings for TYRA's Operating Leases are $5.2 million (Q1 2026), $5.3 million (Q4 2025), and $5.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.21 Mn |
| Dec 31, 2025 | 5.34 Mn |
| Sep 30, 2025 | 5.46 Mn |
| Jun 30, 2025 | 5.58 Mn |
| Mar 31, 2025 | 5.70 Mn |
| Dec 31, 2024 | 5.81 Mn |
| Sep 30, 2024 | 5.92 Mn |
| Jun 30, 2024 | 6.02 Mn |
| Mar 31, 2024 | 6.12 Mn |
| Dec 31, 2023 | 6.22 Mn |
| Sep 30, 2023 | 5.96 Mn |
| Jun 30, 2023 | 5.93 Mn |
| Mar 31, 2023 | 2.44 Mn |
| Dec 31, 2022 | 2.48 Mn |
| Sep 30, 2022 | 2.51 Mn |
| Jun 30, 2022 | 2.55 Mn |
| Mar 31, 2022 | 5.50 Mn |
| Dec 31, 2021 | 981,000.00 |
| Sep 30, 2021 | 1.04 Mn |